Axa S.A. Alkermes Plc. Transaction History

Axa S.A.

$32.3 Billion
Q3 2024

A detailed history of Axa S.A. transactions in Alkermes Plc. stock. As of the latest transaction made, Axa S.A. holds 484,426 shares of ALKS stock, worth $14.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

484,426

Previous 481,257 0.66%

Holding current value

$14.4 Million

Previous $11.6 Million 16.91%

% of portfolio

0.04%

Previous 0.04%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.01 - $28.55 $72,918 - $90,474	3,169 Added 0.66%	484,426 $13.6 Million
Q2 2024 Aug 14, 2024	BUY	$23.21 - $27.24 $3,829 - $4,494	165 Added 0.03%	481,257 $11.6 Million
Q1 2024 May 15, 2024	BUY	$26.4 - $32.56 $4.96 Million - $6.12 Million	187,863 Added 64.07%	481,092 $13 Million
Q4 2023 Jul 16, 2024	SELL	$23.37 - $28.68 $4.39 Million - $5.39 Million	-187,863 Reduced 39.05%	293,229 $8.13 Million
Q4 2023 Feb 14, 2024	SELL	$23.37 - $28.68 $165,786 - $203,455	-7,094 Reduced 2.36%	293,229 $8.13 Million
Q3 2023 Nov 14, 2023	SELL	$27.17 - $31.97 $766,818 - $902,289	-28,223 Reduced 8.59%	300,323 $8.41 Million
Q2 2023 Aug 14, 2023	SELL	$28.34 - $33.63 $295,019 - $350,088	-10,410 Reduced 3.07%	328,546 $10.3 Million
Q1 2023 May 15, 2023	BUY	$25.31 - $29.02 $264,666 - $303,462	10,457 Added 3.18%	338,956 $9.56 Million
Q4 2022 Feb 14, 2023	SELL	$21.94 - $26.24 $38,043 - $45,500	-1,734 Reduced 0.53%	328,499 $8.58 Million
Q3 2022 Feb 14, 2023	BUY	$22.0 - $31.87 $160,490 - $232,491	7,295 Added 2.26%	330,233 $7.37 Million
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $160,490 - $232,491	7,295 Added 2.26%	330,233 $7.37 Million
Q2 2022 Feb 14, 2023	BUY	$26.4 - $30.54 $1.66 Million - $1.92 Million	62,888 Added 24.18%	322,938 $9.62 Million
Q2 2022 Aug 15, 2022	BUY	$26.4 - $30.54 $1.66 Million - $1.92 Million	62,888 Added 24.18%	322,938 $9.62 Million
Q1 2022 Feb 14, 2023	SELL	$23.07 - $27.99 $1.62 Million - $1.96 Million	-70,183 Reduced 21.25%	260,050 $6.84 Million
Q1 2022 May 13, 2022	BUY	$23.07 - $27.99 $6 Million - $7.28 Million	260,050 New	260,050 $6.84 Million
Q4 2021 Feb 14, 2022	SELL	$21.47 - $32.08 $3.83 Million - $5.73 Million	-178,500 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$23.37 - $32.13 $2.15 Million - $2.96 Million	92,200 Added 106.84%	178,500 $5.51 Million
Q1 2021 May 14, 2021	BUY	$18.21 - $23.2 $111,081 - $141,520	6,100 Added 7.61%	86,300 $1.61 Million
Q4 2020 Feb 12, 2021	BUY	$15.39 - $22.1 $944,946 - $1.36 Million	61,400 Added 326.6%	80,200 $1.6 Million
Q2 2020 Aug 14, 2020	BUY	$13.31 - $19.41 $250,228 - $364,908	18,800 New	18,800 $365,000
Q1 2019 May 14, 2019	SELL	$28.4 - $36.49 $6.88 Million - $8.84 Million	-242,295 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$27.94 - $44.61 $1.28 Million - $2.04 Million	-45,680 Reduced 15.86%	242,295 $7.15 Million
Q2 2018 Aug 13, 2018	BUY	$40.56 - $51.36 $1.75 Million - $2.22 Million	43,182 Added 17.64%	287,975 $11.9 Million
Q1 2018 May 14, 2018	SELL	$53.61 - $67.26 $3.35 Million - $4.21 Million	-62,525 Reduced 20.35%	244,793 $14.2 Million
Q4 2017 Feb 13, 2018	BUY	$47.69 - $55.39 $6.7 Million - $7.78 Million	140,392 Added 84.1%	307,318 $16.8 Million
Q3 2017 Nov 13, 2017	BUY	$49.16 - $54.45 $8.21 Million - $9.09 Million	166,926	166,926 $8.49 Million

Others Institutions Holding ALKS

# of Institutions

362

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.87B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account